[go: up one dir, main page]

EP1157714B1 - Beatmungssystem mit eingliedrigem Beatmungsrohr - Google Patents

Beatmungssystem mit eingliedrigem Beatmungsrohr Download PDF

Info

Publication number
EP1157714B1
EP1157714B1 EP01119893A EP01119893A EP1157714B1 EP 1157714 B1 EP1157714 B1 EP 1157714B1 EP 01119893 A EP01119893 A EP 01119893A EP 01119893 A EP01119893 A EP 01119893A EP 1157714 B1 EP1157714 B1 EP 1157714B1
Authority
EP
European Patent Office
Prior art keywords
tube
flexible tube
distal end
breathing circuit
dead space
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP01119893A
Other languages
English (en)
French (fr)
Other versions
EP1157714A2 (de
EP1157714A3 (de
Inventor
Atsuo F. Fukunaga
Blanca M. Fukunaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medlis Corp
Original Assignee
Medlis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medlis Corp filed Critical Medlis Corp
Priority to EP04019779A priority Critical patent/EP1484076A3/de
Priority to EP10185803A priority patent/EP2272558A2/de
Publication of EP1157714A2 publication Critical patent/EP1157714A2/de
Publication of EP1157714A3 publication Critical patent/EP1157714A3/de
Application granted granted Critical
Publication of EP1157714B1 publication Critical patent/EP1157714B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/105—Filters
    • A61M16/1055—Filters bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/43—Composition of exhalation
    • A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/43—Composition of exhalation
    • A61M2230/435—Composition of exhalation partial O2 pressure (P-O2)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/911—Unilimb inhalation-exhalation breathing tubes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/912—Connections and closures for tubes delivering fluids to or from the body
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/914—Rebreathing apparatus for increasing carbon dioxide content in inhaled gas
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S55/00—Gas separation
    • Y10S55/35—Respirators and register filters

Definitions

  • the present invention relates in one aspect to artificial ventilation methods and systems for administering and exhausting gases to a mammal, including methods and systems for use in anesthesia and administration of oxygen to patients, and more particularly to artificial breathing systems capable of controlling carbon dioxide rebreathing.
  • the present invention relates in another aspect to a unilimb inspiratory and expiratory breathing circuit, which has one or more tubular conduits detachable at a common interface, the interface optionally providing for control of gas flow and operable connection to different functional devices.
  • Breathing circuits are utilized to conduct inspiratory gases from a source of same, such as from an anesthetic machine, to a patient, and conduct expiratory gases away from the patient.
  • the gases are conducted through two or more conduits, and, generally, at least a portion of the expiratory gas is recycled to the patient after removal of carbon dioxide.
  • the end of a conduit directed toward a patient shall be referred to as the distal end
  • the end of a conduit facing or connected to a source of inspiratory gases shall be referred to as the proximal end.
  • fittings and terminals at the distal end of the breathing circuit e.g., connecting to or directed at the patient airway device (i.e., endotracheal tube, laryngeal mask, or face mask)
  • distal fittings or terminals fittings and terminals at the proximal end of the breathing circuit
  • proximal fittings and terminals fittings and terminals at the proximal end of the breathing circuit
  • U.S. Patent Number 4,265,235 to Fukunaga, describes a unilimb device of universal application for use in different types of breathing systems, which provides many advantages over prior systems.
  • the Fukunaga system utilizes a space saving coaxial, or tube-within-a-tube, design to provide inspiratory gases and remove expiratory gases.
  • the inner tube is connected at its proximal end to a source of inspiratory, fresh gas, while the outer tube proximal end is connected to an exhaust port and/or to a carbon dioxide absorber (the latter at least partially exhausts into the inspiratory gas source when used in a circle system).
  • the Fukunaga system has additional benefits, such as serving as an artificial nose (expired air warms and humidifies inspired air as the opposing two flows are co-axial in the unilimb device).
  • the Fukunaga circuit is also safer than prior co-axial systems, since the distal end of the inner tube is not connected to the outer tube at a distal fitting, so that the outer tube can be axially extended with respect to the inner tube without disconnecting the proximal end of the inner tube from the source of inspiratory gases; this safety feature can also be used to increase the dead space between the distal ends of the inner tube and outer tube, and thereby allow for adjustment of the amount of expiratory air the patient rebreaths.
  • Dead space is defined herein as the part of the breathing circuit external to the patient which, at the end of expiration, is filled with exhaled gases to be inhaled at the next breath (generally the expired air in the dead space is combined with oxygen and/or other gases provided from a source thereof).
  • the Fukunaga unilimb device is commercially manufactured as the UNIVERSAL FTM by King Systems of Noblesville, IN, USA.
  • the device includes a proximal terminal comprising a hollow, T-shaped housing with three ports: an inspiratory gas port, an expiratory gas port at a perpendicular angle to the inspiratory gas port, and a third ("patient") port.
  • the proximal terminal is connected to an outer tube and a coaxial inner tube, which carry gases to and from the proximal terminal.
  • the outer tube is flexible and corrugated, and formed of a transparent (or semi-transparent) material.
  • the proximal end of the outer tube is sealably connected and bonded to the patient port of the proximal terminal.
  • a dark colored, flexible inner tube is sealably connected and bonded to the inspiratory port, and extends through the T-shaped housing, out the patient port, and passes through most of the axial length of the outer tube.
  • the dark color of the inner tube readily permits the user to see through the outer tube to determine whether the inner tube is properly connected.
  • the inner diameter of the outer tube is sufficiently larger than the outer diameter of the inner tube to permit adequate patient respiration.
  • the distal end of the outer tube is sealably connected and bonded to the exterior of an annular housing which forms a distal terminal.
  • the annular housing of the distal terminal is designed to prevent the distal end of the inner tube from extending beyond the distal end of the outer tube. The entire unit is designed for disposal after a single use.
  • the UNIVERSAL FTM device offers great advantages over prior dual line and unilimb anesthesia circuits, and respiratory assist devices.
  • manufacture of the entire unit requires several complex steps, and must be done with care so that the inner and outer tubes are properly sealed and bonded to the proximal terminal ports at their proximal ends; it is particularly important that the inner tube proximal end be firmly connected to the proximal terminal when the inner tube carries inspiratory gases, since disconnection during use may not allow sufficient oxygen and/or anesthetic gases to reach a patient, which is highly undesirable.
  • the unilimb devices currently used generally comprise a proximal terminal having an integrally connected inner tube and outer tube.
  • the entire unilimb device including the distal terminal, proximal terminal, inner tube and outer tube, is disposed of after a single use, along with multiple devices usually connected to the patient nozzle, such as a CO 2 monitor (capnometer), temperature and humidity controlling and monitoring devices, an O 2 controlling and monitoring device, and an infection controlling device (e.g., a filter).
  • a CO 2 monitor capnometer
  • temperature and humidity controlling and monitoring devices e.g., a temperature and humidity controlling and monitoring devices
  • an O 2 controlling and monitoring device e.g., a filter
  • an infection controlling device e.g., a filter
  • Breathing systems generally provide oxygen to a patient, while removing carbon dioxide produced by the patient.
  • the patient is provided an artificial breathing atmosphere, in which the physician provides a mixture of gases to the patient.
  • the physician may permit the patient to rebreathe some expired gases.
  • Rebreathing simply consists of inhaling gases which have been expired, including carbon dioxide.
  • assisted respiration/ventilation to a patient must be safe, and hypoxia (i.e., patient oxygen deficiency) must be avoided.
  • inspiratory gases are generally provided at high enough pressure, tidal volume and respiratory rate (hyperventilation) to ensure that hypoxia and atelectasis (lung alveolar collapse) is avoided.
  • hypoxia and atelectasis lung alveolar collapse
  • patients are given very high levels of oxygen to avoid hypoxia, but unfortunately they often experience abnormally low carbon dioxide levels (i.e., hypocarbia or hypocapnia), and insufficient carbon dioxide can have a negative impact on vital organs (e.g., brain, heart, splanchnic organs, etc.).
  • the present invention is defined in claim 1. It provides in one aspect an improved unilimb breathing circuit for providing and exhausting gases from a mammal. Further aspects ofthe present invention include new and improved devices for use in ventilation methods and systems.
  • aspects of the present invention relate to the surprising discovery by the inventor that concerns about disconnection of the inner respiratory tube, when connected to the inspiratory port of a proximal terminal in breathing circuits utilizing a unilimb device, such as the UNIVERSAL FTM or the "Bain" circuit, can be eliminated by a new proximal terminal construction, which facilitates the use of tubing which is intentionally made to be readily attachable and detachable to the proximal terminal ports, rather than sealably connected as in present systems, and yet provide improved function, safety, and serviceability.
  • the breathing circuit manufacturing process is greatly simplified by eliminating the steps of sealably bonding the proximal ends of the inner and outer flexible respiratory tubes to the inspiratory and patient ports, respectively, of the unilimb proximal terminal.
  • the new unilimb proximal terminal facilitates the attachment and detachment of respiratory tubing to the proximal terminal, thus resulting in a cheaper and safer breathing circuit.
  • the new unilimb proximal terminal also permits more efficient placement and utilization of the other breathing circuit components in a multifunctional interface incorporating the unilimb proximal terminal.
  • an improved coaxial tube device is provided, which is readily attachable and detachable from the new proximal terminal.
  • the coaxial tube device has an inner tube in fixed spaced coaxial parallel relationship to an outer tube at its proximal end, such that a single step is required to connect both tubes to the proximal terminal. This is made possible by a fitting within or at the proximal ends of the coaxial inner and outer tubes, which still permits the distal end of the inner tube to axially move with respect to the distal end of the outer tube.
  • coaxial refers to the fact that one tube is contained within the other, but the central axis of both tubes need not be aligned.
  • aspects of the present invention involve the surprising discovery by the inventor that hypoxia can be avoided while simultaneously creating intentional dead space in the breathing circuit, thereby increasing rebreathing of expired carbon dioxide, which enables maintenance of normal levels of arterial blood carbon dioxide (i.e., normocapnia) during artificial ventilation.
  • normocapnia normal levels of arterial blood carbon dioxide
  • moderate hypercapnia will not cause hypoxia, provided sufficient oxygen reaches the patient; in fact, moderate hypercapnia can be beneficial to a patient (e.g., improve cardiovascular oxygen availability and tissue oxygenation).
  • the arterial blood carbon dioxide tension (P a CO 2 ) can be predictably controlled via a predetermined dead space created in the unilimb device breathing tubes (i.e., the volume in the outer tube defined by the space between outer tube distal end and inner tube distal end).
  • the dead space volume may be made adjustable by use of axially extendable and compressible corrugated tubing (which does not rebound to its prior length and maintains its approximate internal diameter despite bending and/or axial length changes); the tubing connects at its proximal end to the patient port of the proximal terminal, and may have dead space calibration markings thereon to permit determination and adjustment of dead space volume contained therein.
  • an artificial ventilation method which avoids hypocapnia and hypoxia.
  • the method comprises provision of artificial ventilation to a mammal (in which the mammal inspires and expires spontaneously or with mechanical assistance) sufficient to prevent hypoxia, while permitting a sufficient portion of the mammal's expiratory gases to be rebreathed to allow the arterial carbon dioxide tension of the mammal to be between about 35 mmHg to about 45 mmHg (i.e., normocapnia for a human).
  • the mammal's expiratory gases are rebreathed sufficiently to permit the arterial carbon dioxide tension to be between about 45 mmHg to about 95 mmHg (i.e., moderate hypercapnia).
  • the outer diameter of the inner tube is smaller than the inner diameter of the outer tube, wherein the outer tube can be operably connected at its distal end to a fitting (e.g., endotracheal tube or mask) that can provide artificial ventilation to a mammal.
  • the inner tube is at least partially disposed within the outer tube, and the distal end of the inner tube is disposed within and in direct fluid communication with the outer tube.
  • the proximal end of one of the tubes is connected to an inspiratory gas input (preferably the inner tube), and the proximal end of the other tube is connected to an exhaust outlet.
  • the distal end of the inner tube is axially disposed at a predetermined distance from the distal end of the outer tube to create a dead space in the outer tube between the tube distal ends.
  • the dead space permits the mixing of inspiratory (fresh) gases with expiratory gases from a patient operably connected to the device, and thereby the amount of gases rebreathed by a patient can be related to the dead space volume.
  • This dead space can be predetermined and adjusted to provide for normocapnia or moderate hypercapnia while avoiding hypoxia.
  • an inner tube and outer tube are provided, which, when operably connected to a mammal to provide respiration, the dead space external of the patient is at least 40 cubic centimeters, and may exceed 150 cubic centimeters.
  • the inner tube is of a fixed length and preferably of a dark color (or has a dark colored band about its distal end); the outer tube can have its length adjusted, and is made of a clear (transparent or semi-transparent) material.
  • the dead space may be adjusted by axial extension or contraction of the outer tube to alter the axial distance between the distal end of the outer tube and the distal end of the inner tube.
  • the outer tube can be formed of a section of corrugated tubing, such as for example FLEXITUBE R , which upon axial extension from its compressed axial conformation, or visa versa, will retain its axial length (e.g., will not rebound; i.e., accordion-like pleated tubing).
  • the FLEXITUBE R when bent, will retain the angle of curvature it is bent to without substantial reduction in the tube's inner diameter.
  • Suitable corrugated tubing for use in the present invention is used in the Ultra-Flex circuit from King Systems Corporation, of Noblesville, IN, U.S.A.
  • the inner tube can be seen through the outer tube and, in one embodiment, the dead space volume can be determined by reference to calibration markings, which are on the outer tube, aligned with the distal end of the inner tube.
  • Suitable prior art biological contamination filter means which can be used in some embodiments of the present invention, is the VIROBAC II Mini-Filter by King Systems.
  • other adapters and a variety of single use devices previously connected at the distal or patient fittings, can be reused by connection to the interface at the proximal side of the biological contamination filter. Since the proximal terminal is more complicated to manufacture, this invention permits substantial cost savings by permitting reuse of the proximal terminal and other devices connected thereto, while simultaneously reducing environmental (medical) wastes.
  • the present invention includes a system for use in mammals to provide respiratory and other gases.
  • the system comprises a first breathing conduit having a proximal end and a distal end for providing and exhausting respiratory gases from a mammal, and an interface comprising a breathing circuit operably connected to the proximal end of the first breathing conduit.
  • a biological contamination filter blocks biological contaminants in the first breathing conduit from communicating with the interface components while allowing for adequate transmission of inspiratory and expiratory flows.
  • the biological contamination filter can be located within the proximal end of the first breathing conduit, or serve as a separate detachable component.
  • a coaxial filter-within-a-filter may be provided.
  • the filter apparatus comprises an inner housing having openings at its opposite ends; at least one of the openings has an internal diameter which equals the internal diameter of the inner tube of the breathing conduit, so that the filter device may be attached in a coaxial fashion with the inner tube of the breathing conduit.
  • the inner diameter of the filter device inner housing expands to form a chamber which accommodates a filter having a predetermined diameter to permit sufficient flow therethrough (i.e., flow resistance is inversely proportional to filter surface area).
  • the inner housing is contained within, and in spaced parallel relationship with, an outer housing which is similar or identical in shape, but of sufficiently greater internal diameter throughout to permit fluid to flow between the outer walls of the inner housing and the inner walls of the outer housing.
  • a single disc shaped filter may be contained within the inner housing and radially extend from within the inner housing chamber to the outer housing chamber, or a filter in the shape of an annular ring may be disposed about the outer diameter of the inner housing filter chamber and extend to the inner wall of the outer housing chamber.
  • the inner and outer filter housings may each be constructed from two funnel shaped components, a pre-filtration housing and postfiltration housing (which are mirror images of each other); the two components can be assembled together after placing a filter therebetween at the center of the filter chambers to be formed thereby.
  • the interface of a preferred embodiment comprises a T-shaped housing, having an inspiratory gas input (inspiratory port), an expiratory gas outlet (expiratory port), and a first respiratory (patient) port.
  • the first respiratory port can be placed in fluid communication, through the biological contamination filter, with a first breathing (respiratory) conduit leading to a patient.
  • the inspiratory port of the proximal terminal connects to and is integral with an internal conduit, which passes through the housing of the proximal terminal, so that the distal end of the internal conduit forms a second respiratory port, which terminates within the first respiratory port.
  • the second respiratory port has a smaller diameter than the first respiratory port, so that gases may flow through the first respiratory port through the space between the exterior wall of the inner conduit and the interior wall of the proximal terminal housing.
  • the new proximal terminal permits the ready connection and disconnection of an inner tube of a coaxial respiratory conduit to the inspiratory gas source. since direct sealed fluid communication with the inspiratory port is greatly facilitated by the inner conduit of the new proximal terminal housing.
  • the prior art difficulties with connection of the inner tube of unilimb devices to the inspiratory port are eliminated, making it possible to avoid sealably bonding the inner flexible respiratory tube to the inspiratory port of the proximal terminal during manufacture.
  • the inner tube carries inspiratory gases from an inspiratory gas source
  • the outer tube carries expiratory gases.
  • inspiratory gas flow be laminar
  • the expiratory gas flow should be turbulent.
  • Turbulent expiratory gas flow is facilitated by the annular shape of the passage between the inner wall of the outer tube and outer wall of the inner tube, as well as by the confluence of gases exiting from the inner tube distal end into the dead space with expiratory air.
  • filtration of the expiratory gases increases turbulent flow in the outer tube, causing a positive end expiratory pressure (PEEP) effect, which helps to maintain positive pressure in the patient airway (to prevent atelectasis).
  • PEEP positive end expiratory pressure
  • the filter-within-a-filter device helps create turbulent flow in the expiratory gases, when the outer tube is used as the expiatory gas conduit.
  • the first breathing or respiratory conduit forming part of the present invention includes one tube, referred to herein for simplicity as the outer tube, and has a first (proximal) end and a second (distal) end.
  • the outer tube may be connected at its first end through a filter device to the first respiratory port, and has its second, or distal, end directed toward the patient. Both the first and second respiratory ports may terminate in and may be in fluid communication with the proximal end of the outer tube through one or more biological filters.
  • the first breathing conduit between the patient and the proximal terminal can comprise a single tube, the entire length of which provides a dead space, or mixing chamber for inspiratory and expiratory gases.
  • the first breathing conduit is detachable from the proximal terminal for disposal or sterilization.
  • proximal terminal of prior art unilimb devices such as the UNIVERSAL FTM, is no longer disposed of after a single use, and may be a permanent part of the interface.
  • the respiratory conduit may comprise an outer flexible tube, the length of which can be preselected from various lengths to vary the dead space to a preselected volume.
  • the outer tube can be axially expandable and compressible (i.e., have accordion-like pleats) to make the dead space adjustable; the dead space can be determined by reference to calibration markings on the outer tube.
  • the calibration markings on the pleated tube may be concealed in the folded pleats, and revealed in opened pleats.
  • the calibration markings may be color-coded bands.
  • the first breathing conduit further comprises an inner flexible tube axially disposed within the flexible outer tube.
  • the inner tube proximal end is connected through a biological contamination filter to the second respiratory port, and the distal end of the inner tube terminates inside of the outer tube.
  • the dead space can be adjusted by adjusting the axial distance between the outer tube distal end and inner tube distal end.
  • the proximal end of the flexible inner tube and the proximal end of the flexible outer tube are held in spaced parallel coaxial relationship by a rigid fitting, formed of coaxial rigid annuli, a smaller annulus within a larger annulus, which are held in fixed spaced relationship by rigid radial struts extending from the exterior of the inner annulus to the interior of the exterior annulus; in one embodiment, the struts do not extend to the ends of the inner annulus to permit a flexible conduit to be connected thereover.
  • the fitting connects to the distal end of a filter device, which has a threaded or flanged connector at its proximal end to permit secure attachment to, and simple detachment from, the first and second respiratory ports.
  • the internal conduit of the interface proximal terminal carries inspiratory gases to the second respiratory port
  • the outer tube of the interface carries expiratory gases entering from the first respiratory port.
  • the outer tube may be of variable length to permit adjustment of the dead space; calibration markings on a clear outer tube may be aligned with the end of the inner tube to determine dead space volume.
  • first and second respiratory ports in the distal end of the proximal terminal permits biological isolation of the first breathing conduit, whether it comprises only an outer tube connected to the first respiratory port, or a coaxial outer tube and inner tube, which are connected to the first and second respiratory ports, respectively.
  • first breathing conduit whether it comprises only an outer tube connected to the first respiratory port, or a coaxial outer tube and inner tube, which are connected to the first and second respiratory ports, respectively.
  • the new interface permits numerous monitoring and control devices to be included in the interface at the proximal end of the biological filter(s).
  • Various devices contained in detachable modules can be repeatedly utilized with the interface, including devices which were formerly attached to the patient nozzle and disposed of after a single-use.
  • the new assisted breathing circuit of the present invention provides for greatly simplified construction of disposable unilimb single use components, which reduces costs of production and at the same time reduces the quantity of materials requiring replacement after a single use. Further, fewer devices need be crowded about the patient, providing improved surgical safety (less clutter at the patient makes for easier surgical access and safety). Insertion of monitoring and control devices at the proximal, post filtration, end of the breathing system, permits improved control and monitoring of the patients' respiration with a simpler device.
  • the present invention provides a simpler artificial ventilation system, that is easier and less expensive to construct than prior art systems, is easier, safer and less expensive to use, yet provides improved features. Further, the present invention makes possible safer artificial ventilation by providing means and a method for simultaneously preventing hypoxia and hypocapnia. Further details and advantages of the present invention will be appreciated by reference to the figures and description of exemplary embodiments set forth herein.
  • FIG. 1 a schematic view of a circle circuit artificial ventilation system utilizing a unilimb respiratory (inspiratory and expiratory gas) conduit is illustrated.
  • a unilimb respiratory (or breathing) conduit 1 may be attached at outlet 2 (otherwise referred to as a nozzle or distal terminal) to a patient endotracheal tube or mask.
  • Breathing conduit 1 is formed out of an outer tube 4 and an inner tube 5.
  • Directional arrows 7 show the preferred direction of gas flow through the system; for example, expiratory air is carried away from a patient through the annular spacing between inner tube 5 and outer tube 4.
  • Inner tube 5 penetrates the wall of proximal terminal housing 11; housing 11 essentially comprises a bend in outer tube 4, and the outer wall of tube 5 may be integrally sealed thereto.
  • a carbon dioxide absorber 13 may be used to remove carbon dioxide from expiratory gases passed therethrough, and the thus-filtered gases combined with inspiratory fresh gases from source 8. Expiratory gases pass from a patient outlet 2 through outer tube 4, then through unidirectional valve 15 to be recirculated or vented at exhaust port 17.
  • a Fukunaga unilimb device such as that described in detail in U.S. Patent Number 4,265,235 is illustrated.
  • the device comprises a T-shaped proximal terminal 20, a distal terminal 30, a flexible inner tube 40, and a flexible outer tube 50. Since the diameter of inner tube 40 is smaller than the diameter of outer tube 50, an annular space 41 is formed therebetween.
  • the distal end 51 of outer tube 50 is connected to distal terminal 30, which has means 31 for preventing the distal end 42 of inner tube 40 from extending beyond distal terminal 30. Distal end 42 is free of terminal 30 and outer tube 50.
  • the T-shaped housing of proximal terminal 20 includes an inspiratory port 22, and expiratory port 24, and a patient port 26.
  • Inner tube 40 is connected at its proximal end to inspiratory port 22, and passes through proximal terminal 20 and out of patient port 26.
  • the remote location of inspiratory port 22 from patient port 26 makes it desirable to sealably bond the distal end 28 of inner tube 40 to inspiratory port 22, or, optionally, a continuous length of inner tube 40 extends proximally of inspiratory port 22, and distally of patient port 26 to at or near distal end 51 of outer tube 50 (inner tube 40 acting to seal, or being sealably bonded to, inspiratory port 22 at the point of intersection therewith).
  • outer tube 50 is bonded at its proximal end 52 to the outer wall 29 of patient port 26, and is bonded at its distal end 51 to distal terminal 30.
  • Proximal terminal 60 comprises a rigid, unitary T-shaped housing, having an inspiratory port 62, an expiratory port 64, a first respiratory port 66, and a second respiratory port 68.
  • Inspiratory port 62 has a step-wise taper from a wider-diameter proximal end 63 to a narrow diameter distal end 65, although the taper may be smooth and continuous, or have other shapes.
  • An inner conduit 70 having a proximal end 71 and a distal end 72 is sealably connected and bonded to inspiratory port 62 at fitting 74.
  • the outer diameter of inner conduit 70 is sealably bonded to distal end 65 of inspiratory port 62, so as to be integral therewith.
  • An integral annular wall 75 forms the distal end 65 of inspiratory port 62.
  • First respiratory port 66 and second respiratory port 68 form concentric ports about axis line 78, preferably having their concentric openings in the same plane which is perpendicular to axis line 78 of inner conduit 70.
  • second respiratory port 68 while shown axially centered or concentric, within first respiratory port 66, may be off-center with respect to axis line 78 (although this would require that at least a portion of inner conduit 70 to likewise be off-center with respect to axis line 78).
  • Inner conduit 70 may axially extend outward slightly from first respiratory port 66 so as to further facilitate connection of a tube to second respiratory port 68.
  • Optional flanges 76 may be provided at second respiratory report 68 and/or first respiratory port 66 in order to engage matching threads or flanges of detachable tubular fittings which may be attached thereto.
  • the new proximal terminal may be formed of rigid plastic, such as is typically used in rigid attachments to artificial ventilation systems. Since the new proximal terminal is designed for multi-use, it may also be formed of metal, such as stainless steel. If the terminal is formed of plastic (such as that used in the UNIVERSAL FTM proximal terminal), if may be clear, translucent or opaque. It is important that the walls of the proximal terminal housing near and at the ports have sufficient rigidity to permit connection to conduits, such as the patient respiratory conduit tubes, and conduits connecting to the inspiratory and expiratory ports.
  • Proximal terminal 60 is intended to be manufactured and shipped as a component independent of flexible breathing or respiratory conduit(s) which would lead to a patient, rather than being integrally bound during manufacture to flexible respiratory conduits as with prior art unilimb devices. Therefore, it need not be disposed of or sterilized after a single use, and it may be incorporated in a single unit, such as interface 80, along with other functional devices 81, 82, 83, and 84, which are illustrated here in block diagram form for simplicity, or it can be placed before or after interface 80.
  • proximal terminal 60 The flexibility of new proximal terminal 60 is illustrated by showing it in block form in interface 80, as well as at an optional location 60A. Although four functional devices 81-84 are incorporated in interface 80, more or less than this number may be used. Functional devices may be in the form of readily attachable and detachable modules, so that the ventilation system may be easily modified to meet the requirements of the user. Further, a varying number of optional functional devices, such as devices 85, 86, 87, 88, and 89 may be incorporated in the system, both proximal and distal of proximal terminal 60 or 60A.
  • devices 85, 86, 87, 88, and 89 may be incorporated in the system, both proximal and distal of proximal terminal 60 or 60A.
  • a coaxial breathing conduit 100 (described in more detail below) is connected at its proximal end to functional devices 85 and 86, which in turn are connected to biological filter 90 (another embodiment of which is described in detail below). Inspiratory and expiratory gases must pass through filter 90, thus isolating interface 80, and other system components connected proximally of filter 90, from contamination (infection) by patient expiratory gases conducted by conduit 100.
  • devices 85 and 86 may comprise an O 2 controller (for air dilution) and a CO 2 controller (e.g., a rebreathing shunt hole).
  • a reservoir bag (useful during patient transport and/or resuscitation) may be connected at, distal, or proximal of filter 90.
  • Devices 81-84, 87-89 may likewise perform control and/or monitoring functions.
  • devices in modular form can be added so that oxygen can be monitored by an oxygen sensor, and controlled by an air dilution valve; carbon dioxide can be monitored by a capnometer, and controlled by a rebreathing shunt hole; anesthetic gases can be monitored by sensors and controlled by an anesthesia machine; and temperature and humidity can be monitored by appropriate devices, and controlled by an artificial nose.
  • Breathing conduit 100 consists of a flexible inner tube 110 and a flexible outer tube 120, both connected to proximal fitting 130.
  • Inner tube 110 and outer tube 120 are kept in spaced coaxial relationship at their proximal connection to fitting 130.
  • Fitting 130 has radial flanges 132 which keep rigid inner pipe 134 connected to but spaced from rigid outer pipe 136.
  • Threads or flanges may be optionally provided on inner pipe 134 and/or outer pipe 136 to permit engagement with flanges or threads at second respiratory port 68 and/or first respiratory port 66, or to permit connection to a filter device, which in turn connects to second respiratory port 68 and/or first respiratory port 66.
  • Distal end 122 of flexible outer tube 120 connects to a rigid annular distal terminal 124.
  • the distal end 112 of flexible inner tube 110 does not axially extend beyond distal terminal 124 or the distal end 122 of outer tube 120.
  • the distal end 112 of flexible inner tube 110 may optionally be connected to distal terminal 124 or to the distal end 122 of outer tube 120, or may be free to move axially within tube 120.
  • the distance between distal end 112 of flexible inner tube 110 and the distal end 122 of flexible outer tube 120 defines a dead space 138.
  • varying lengths of flexible inner tube 110 and/or flexible outer tube 120 are utilized in order to vary the size of the dead space to a predetermined volume.
  • outer tube 120 is formed of adjustable-length tubing, so that the dead space can be adjusted by extending or compressing the outer tubing axial length.
  • the outer tubing may be formed of transparent or semi-transparent material, and calibration markings may be included thereon to permit determination of dead space volume by alignment of the distal end 112 of inner tube 110 with the markings.
  • flexible tubes 110 and 120 are readily attachable to and detachable from fitting 130, and flexible tube 120 is readily attachable to and detachable from distal terminal 124.
  • flexible tube 110 is not utilized, so that the entire length of tube 120 constitutes dead space.
  • tube 110 and/or tube 120 connect directly to an interface, which incorporates proximal terminal 60; a biological filter is located between the proximal terminal and tubes 110 and 120.
  • Filter 140 includes an inner housing 150 and an outer housing 160.
  • Inner housing 150 is formed of tubular conduits 152 and 154 connected to opposed openings in filter chamber 156, which contains a first or inner filter 158.
  • Outer housing 160 is formed of tubular conduits 162 and 164 connected to opposed openings in filter chamber 166, which contains a second or outer filter 168.
  • Flanges or threads may be provided at one or more of the tubular conduit ends 153, 155, 163, and 165, so that the filter may be secured in axial relationship to other tubular fittings.
  • filter device 140 is connected to a proximal terminal, such as proximal terminal 60 in Fig. 3, so that inner, tubular conduit 152 is sealably connected to the second respiratory port and outer, tubular conduit 162 is sealable connected to the first respiratory port.
  • inspiratory gases pass into tubular conduit 152, pass through filter 158, and out of tubular conduit 154 into a breathing conduit, such as breathing conduit 100 illustrated in Fig. 5, leading to a patient.
  • Expiratory gases pass out of a breathing conduit into the annular spacing between outer, tubular conduit 164 and inner, tubular conduit 154; the expiratory gases then pass through filter 168, into tubular conduit 162, and into the proximal terminal and out of the expiratory port of the proximal terminal, such as port 64 in proximal terminal 60 in Fig. 3.
  • the preceding gas flow pattern can be reversed if desired.
  • filters 158 and 168 can be coplanar, and may even be formed of a single filter disc passing from the inner wall of the outer filter chamber through the wall of the inner filter chamber.
  • inner tubular conduit 152 may axially extend from the end 163 of tubular conduit 162; the extension of tubular conduit 152 is sufficiently long to reach and sealably connect to the inspiratory port of a prior art proximal terminal, which lacks the inner conduit of the new proximal terminal of the present invention.
  • an optional tubular extension 135 is illustrated in an exploded view, and may be connected to end 137 of the inner pipe 134. Extension 135, when connected to end 137 is sufficiently long to reach and sealably connect to the inspiratory port of a prior art proximal terminal, which lacks the inner conduit of the new proximal terminal of the present invention.
  • the patient, or respiratory, conduit comprises a flexible tube with a diameter between 22 mm and 28 mm, and a length between 100 cm and 1.5 meters.
  • the diameter (or D) is preferably between 11 mm and 15 mm.
  • a 22 mm diameter is desirable for adult use, and a 15 mm diameter is desirable for pediatric use.
  • a 28 mm diameter outer tube and 15 mm diameter inner tube are preferred.
  • first (outer) and second (inner) respiratory ports of the proximal terminal have inner diameters which are approximately equal to that of the outer tube and inner tube, respectively.
  • the inner and outer conduits at the opposed ends of the coaxial filter have inner diameters which are preferably approximately equal to that of the outer tube and inner tube, respectively; and the inner and outer annuli of the proximal fitting have inner diameters which are preferably approximately equal to that of the outer tube and inner tube, respectively.
  • a new unilimb artificial ventilation system which according to the invention includes a new patient conduit.
  • a new coaxial filter, and a new proximal terminal, the latter of which may be incorporated into a new multifunctional interface may additionally be provided.
  • these new devices are less expensive to manufacture; are easier to use; and have a wider range of uses and configurations than prior art systems; these new devices reduce medical wastes, since more components can be reused; yet, these devices are safer to use, due to the reduction of equipment required at the patient terminal, and provide for greater monitoring and control.
  • the unilimb artificial ventilation circuit of the present invention is ideal for providing artificial ventilation to a patient in which hypoxia is avoided while safely avoiding hypocapnia or even providing moderate hypercapnia. It was surprisingly discovered that normal carbon dioxide levels (normocapnia), or even moderate hypercapnia could be safely induced and/or maintained in a patient without causing hypoxia, as demonstrated by extensive data from human subjects, which dramatically illustrates this surprising discovery, and how the unilimb dead space volume can be adjusted to achieve normocapnia or moderate hypercapnia without causing hypoxia.
  • hypocapnia Adverse effects of hypocapnia include: a) Vital organ tissue ischemia/hypoxia, since hypocapnia decreases cerebral, myocardial and splanchnic blood flow, and shifts the oxygen dissociation curve to the left, making the release of oxygen to the tissues difficult; b) Hypocapnia causes reduction of cardiac output and thus decreases the oxygen delivery (i.e.
  • Hypocapnia causes severe vasoconstriction of some tissues such as the skin
  • Hypocapnia causes blood and tissue biochemical disturbances: Anaerobic metabolism increases blood lactic acid concentration; and changes in plasma electrolytes (sodium, potassium, calcium, etc.) cause cardiac arrhythmias, metabolic acidosis, tetany, etc.
  • V D ventilation apparatus dead space
  • PaCO 2 arterial blood carbon dioxide tension
  • PaO 2 oxygen tension
  • Anesthesia was maintained with 60-70 % nitrous oxide in oxygen and 0.5-1.0 % halothane, or 0.8-1.5 % enflurane, using a conventional anesthesia circle breathing system with CO 2 absorption. Intraoperative muscle relaxation was achieved with intermittent pancuronium bromide as required.
  • Table 1 shows that the traditional mode of artificial ventilation using IPPV with no apparatus dead space inevitably resulted in a marked decrease in arterial carbon dioxide tension (PaCO 2 ) i.e., hypocapnia.
  • PaCO 2 arterial carbon dioxide tension
  • V D 160-200 ml
  • V D 350 ml
  • V D 550 ml
  • Study II shows a mathematical regression analysis of the blood gas data obtained from 60 patients (120 samples) during artificial ventilation with varied dead space volumes.
  • a predetermined volume of dead space in the breathing circuit can significantly control the PaCO 2 values without evidence of hypoxia during artificial ventilation, as illustrated in Figures 7-10 and Table 1.
  • Maintenance of normocapnic levels may be highly desirable and beneficial to the patients during anesthesia and/or to patients undergoing artificial ventilation, for example in the ICU.
  • V D dead space volume
  • Figure 8 is a graphic illustration of the independence of P a O 2 as V D is varied between about 0 and 8 ml/kg, including a linear regression analysis curve which shows no significant correlation (r is only 0.074) between the two variables in the range tested. Thus, even when dead space volume is large enough to increase P a CO 2 by 15 mmHg (see Fig. 7), there is no significant reduction in P a O 2 .
  • Figure 9 is a graphic illustration of the independence of changes in P a CO 2 and P a O 2 as P a CO 2 was varied between 0 and 25 mmHg, including a linear regression analysis curve having a correlation coefficient, r, of 0.153, thus showing that increasing P a O 2 between 0 and 25 mmHg has no significant effect on P a O 2 .
  • the table of Fig. 10 is generated by the results of data showed in the graph of Fig. 7 of Study II.
  • the artificial ventilation method presented provides for increasing the dead space volume external to a patient to induce and/or maintain normocapnia or moderate hypercapnia while avoiding hypoxia.
  • the anatomical dead space present in a patient's respiratory system including for example that formed by the upper airway (i.e., nose, mouth, laryngeal cavity), trachea and bronchial trees, is at least partially eliminated by endotracheal intubation devices.
  • endotracheal intubation devices i.e., endotracheal intubation devices.
  • inspiratory oxygen is provided at high pressure, large tidal volume and rapid respiratory rate; this results in hyperventilation and considerable reduction in concentration of arterial carbon dioxide.
  • the dead space volume in a unilimb patient respiratory conduit is adjusted to at least 40 ml (cc 3 ).
  • cc 3 the dead space volume in a unilimb patient respiratory conduit is adjusted to at least 40 ml (cc 3 ).
  • carbon dioxide from an external source may be combined with the inspiratory gases, or a dual limb system may be used, in which additional carbon dioxide is supplied to the patient.
  • a Y-shaped fitting 180 is illustrated, which has an input port 182, an exhaust port 184, and a respiratory port 186.
  • Fitting 180 is connected at its distal end to a filter device 190.
  • One way valves, not shown, are proximal of ports 182 and 184 to ensure intermittent positive pressure ventilation.
  • a flexible tube 200 is attached at its proximal end 202 to the distal end of filter device 190.
  • the length and diameter of tube 200 may be selected to achieve a predetermined dead space.
  • Tube 200 and filter device 190 may be sealably bonded together, or separate easily attachable and detachable components.
  • Tube 200 can be of varying predetermined lengths of uniform diameter for preselected dead space volume; tube 200 may have axial adjustable length, and have calibration markings at its opposed ends, the distance between the distal and proximal markings thereon precalculated to provide a predetermined dead space (in one embodiment, distal calibration markings can only be seen when the surrounding flexible pleated tubing is axially extended, and are not legible when the surrounding tube pleats are in their folded axially compressed state).
  • artificial ventilation is provided to a mammal (e.g., a human) sufficient to prevent hypoxia, while a sufficient portion of the mammal's expiratory gases are rebreathed to permit the arterial carbon dioxide tension of the mammal to be between about 35 mmHg and about 95 mmHg, and, in another preferred method, the arterial carbon dioxide level of the mammal is kept between about 35 mmHg and about 45 mmHg (i.e., normocapnia).
  • a mammal e.g., a human
  • the arterial carbon dioxide level of the mammal is kept between about 35 mmHg and about 45 mmHg (i.e., normocapnia).
  • tubular conduits of varying cross-sectional shape may be used, and that the inner tube of a coaxial tube may or may not be axially centered within the outer tube, or only portions of the inner tube may be axially centered in the outer tube while other portions may be offcenter.
  • a proximal terminal may have more than two conduits passing therethrough, which may connect to a flexible respiratory conduit having more than two lumens.

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Ventilation (AREA)
  • Air Conditioning Control Device (AREA)
  • Rigid Pipes And Flexible Pipes (AREA)
  • Medicinal Preparation (AREA)
  • Treating Waste Gases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quick-Acting Or Multi-Walled Pipe Joints (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Noise Elimination (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Devices For Medical Bathing And Washing (AREA)

Claims (13)

  1. Eingliedrige Atemleitung, umfassend eine flexible Röhre (200) mit einem proximalen Ende (202) und einem distalen Ende, wobei die flexible Röhre betrieblich am distalen Ende (202) eines ersten Beatmungsdurchgangs, der Inhalationsgas (182) bereitstellt, und an einem zweiten Beatmungsdurchgang zum Ausatmen von Exhalationsgas (184) über einen proximalen Anschluss (180, 60) anschließbar ist und das distale Ende im. Betrieb zu einem Säuger- oder einem menschlichen Patienten weist, wobei die Vorrichtung dadurch gekennzeichnet ist, dass:
    das Totraumvolumen in der mit der flexiblen Röhre (200) konstruierten Atemleitung durch das Volumen in der flexiblen Röhre distal vom distalen Ende des das Inhalationsgas bereitstellenden Beatmungsdurchgangs bestimmt ist und zwischen 40 ccm und 1000 ccm einstellbar ist.
  2. Atemleitung nach Anspruch 1, weiterhin umfassend einen Filter (190), durch welchen die flexible Röhre (200) operativ mit einem proximalen Anschluss (180, 60) verbunden werden kann.
  3. Atemleitung nach Anspruch 1 oder 2, dadurch gekennzeichnet, dass das Totraumvolumen bei einer mit der flexiblen Röhre konstruierten Atemleitung durch Einstellen der Länge der flexiblen Röhre einstellbar ist.
  4. Atemleitung nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, dass die flexible Röhre eine äußere flexible Röhre (120) und eine innere flexible Röhre (110) umfasst, wobei die innere flexible Röhre zumindest teilweise innerhalb der äußeren Röhre angeordnet ist, wobei das distale Ende der inneren flexiblen Röhre innerhalb der äußeren flexiblen Röhre endet und das Totvolumen (138) durch das Volumen in der äußeren flexiblen Röhre distal vom distalen Ende der inneren flexiblen Röhre bestimmt wird.
  5. Atemleitung nach Anspruch 4, dadurch gekennzeichnet, dass der Totraum durch Einstellen des axialen Abstands zwischen dem distalen Ende (122) der äußeren Röhre und dem distalen Ende (112) der inneren Röhre einstellbar ist.
  6. Atemleitung nach Anspruch 4 oder 5, dadurch gekennzeichnet, dass das proximale Ende der flexiblen inneren Röhre und das proximale Ende der flexiblen äußeren Röhre durch eine starre Armatur (130) in paralleler koaxialer Beziehung gehalten sind.
  7. Atemleitung nach Anspruch 6, dadurch gekennzeichnet, dass die starre Armatur aus koaxial starren Ringen mit einem kleineren Ring innerhalb eines größeren Rings gebildet ist, die durch starre radiale Streben, welche sich vom Äußeren des inneren Rings zum Inneren des äußeren Rings erstrecken, in einer festen räumlichen Beziehung gehalten sind.
  8. Atemleitung nach Anspruch 3, dadurch gekennzeichnet, dass sich auf der flexiblen Röhre Kalibrierungsmarkierungen befinden, um den Totraum zu bestimmen.
  9. Atemleitung nach Anspruch 8, wobei die flexible Röhre gefaltet ist und die Kalibrierungsmarkierungen in zusammengefalteten Falten verdeckt und in geöffneten Falten enthüllt sein können.
  10. Atemleitung nach Anspruch 5, dadurch gekennzeichnet, dass sich auf der äußeren flexiblen Röhre Kalibrierungsmarkierungen befinden, um den Totraum zu bestimmen, wobei die äußere flexible Röhre gefaltet ist und die Kalibrierungsmarkierungen in zusammengefalteten Falten verdeckt und in geöffneten Falten enthüllt sein können.
  11. Atemleitung nach Anspruch 6, 7 oder 9, wobei die Armatur mit dem distalen Ende einer Filtervorrichtung verbindbar ist, die einen Friktionssitz-, Gewinde- oder Flanschverbinder an ihrem proximalen Ende aufweist, um ein sicheres Anbringen an und einfaches Entfernen von den ersten und zweiten Beatmungsdurchgängen zu gestatten.
  12. Atemleitung nach einem der vorstehenden Ansprüche, wobei, wenn in einem gestützten Beatmungssystem und an einem Säuger so angeschlossen, dass Inhalationsgase zum und Exhalationsgase vom Säuger hindurchgehen, unabhängig von Abmessungen und Volumina der flexiblen Röhre der Totraum größer als 100 ccm ist.
  13. Atemleitung nach einem der vorstehenden Ansprüche, wobei das proximale Ende der flexiblen Röhre betrieblich mit dem distalen Ende des proximalen Anschlusses verbunden ist und sie proximal vom distalen Ende des proximalen Anschlusses auseinanderlaufen.
EP01119893A 1996-11-18 1997-10-30 Beatmungssystem mit eingliedrigem Beatmungsrohr Expired - Lifetime EP1157714B1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP04019779A EP1484076A3 (de) 1996-11-18 1997-10-30 System Gerät zur künstlichen Beatmung
EP10185803A EP2272558A2 (de) 1996-11-18 1997-10-30 Künstliches Beatmungssystem

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US751316 1996-11-18
US08/751,316 US5778872A (en) 1996-11-18 1996-11-18 Artificial ventilation system and methods of controlling carbon dioxide rebreathing
EP97947313A EP0942763B1 (de) 1996-11-18 1997-10-30 Proximales anschlussstück für ein eingliedriges beatmungsrohr

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP97947313A Division EP0942763B1 (de) 1996-11-18 1997-10-30 Proximales anschlussstück für ein eingliedriges beatmungsrohr

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP04019779A Division EP1484076A3 (de) 1996-11-18 1997-10-30 System Gerät zur künstlichen Beatmung

Publications (3)

Publication Number Publication Date
EP1157714A2 EP1157714A2 (de) 2001-11-28
EP1157714A3 EP1157714A3 (de) 2002-07-24
EP1157714B1 true EP1157714B1 (de) 2004-09-01

Family

ID=25021463

Family Applications (5)

Application Number Title Priority Date Filing Date
EP04019779A Withdrawn EP1484076A3 (de) 1996-11-18 1997-10-30 System Gerät zur künstlichen Beatmung
EP01119893A Expired - Lifetime EP1157714B1 (de) 1996-11-18 1997-10-30 Beatmungssystem mit eingliedrigem Beatmungsrohr
EP97947313A Expired - Lifetime EP0942763B1 (de) 1996-11-18 1997-10-30 Proximales anschlussstück für ein eingliedriges beatmungsrohr
EP10185803A Withdrawn EP2272558A2 (de) 1996-11-18 1997-10-30 Künstliches Beatmungssystem
EP01117999A Expired - Lifetime EP1155709B1 (de) 1996-11-18 1997-10-30 Filter für eingliedrige beatmungsrohre mit mehreren lumen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP04019779A Withdrawn EP1484076A3 (de) 1996-11-18 1997-10-30 System Gerät zur künstlichen Beatmung

Family Applications After (3)

Application Number Title Priority Date Filing Date
EP97947313A Expired - Lifetime EP0942763B1 (de) 1996-11-18 1997-10-30 Proximales anschlussstück für ein eingliedriges beatmungsrohr
EP10185803A Withdrawn EP2272558A2 (de) 1996-11-18 1997-10-30 Künstliches Beatmungssystem
EP01117999A Expired - Lifetime EP1155709B1 (de) 1996-11-18 1997-10-30 Filter für eingliedrige beatmungsrohre mit mehreren lumen

Country Status (17)

Country Link
US (5) US5778872A (de)
EP (5) EP1484076A3 (de)
JP (5) JP3466203B2 (de)
CN (3) CN1613520B (de)
AT (3) ATE274958T1 (de)
AU (1) AU732019B2 (de)
BR (1) BR9713000A (de)
CA (2) CA2708934C (de)
DE (3) DE69730540T2 (de)
ES (1) ES2205260T3 (de)
HK (2) HK1023954A1 (de)
IL (1) IL129586A (de)
NZ (1) NZ335100A (de)
PT (1) PT942763E (de)
TW (1) TW357089B (de)
WO (1) WO1998022172A1 (de)
ZA (1) ZA9710216B (de)

Families Citing this family (190)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6155252A (en) * 1995-03-17 2000-12-05 Board Of Regents, The University Of Texas System Method and apparatus for directing air flow within an intubated patient
US5878745A (en) 1996-03-01 1999-03-09 Brain; Archibald I.J. Gastro-laryngeal mask
US6439231B1 (en) * 1996-11-18 2002-08-27 Medlis Corp. Artificial ventilation systems and components thereof, and methods for providing, assembling and utilizing same
US6003511A (en) 1996-11-18 1999-12-21 Medlis Corp. Respiratory circuit terminal for a unilimb respiratory device
US5778872A (en) * 1996-11-18 1998-07-14 Medlis, Inc. Artificial ventilation system and methods of controlling carbon dioxide rebreathing
US6306098B1 (en) * 1996-12-19 2001-10-23 Novametrix Medical Systems Inc. Apparatus and method for non-invasively measuring cardiac output
FR2758089B1 (fr) * 1997-01-06 1999-03-05 Georges Boussignac Procede et dispositif pour echanger des sondes respiratoires dans la trachee d'un patient
US5937851A (en) * 1997-02-27 1999-08-17 Respironics, Inc. Swivel device utilizing bearing clearance to allow carbon dioxide laden exhaust
US6571792B1 (en) * 1997-10-15 2003-06-03 Datex-Ohmeda, Inc. Smart modular anesthesia respiratory system
US6125847A (en) * 1997-10-22 2000-10-03 Lin; Chung-Yuan Anesthetic applicator with a temperature humidity regulating capability
GB9727367D0 (en) 1997-12-24 1998-02-25 Brain Archibald Ian Jeremy Improvements in laryngeal mask airway devices
US7331346B2 (en) 1997-12-24 2008-02-19 Indian Ocean Medical, Inc. Monitoring and control for a laryngeal mask airway device
WO1999044664A2 (en) 1998-03-05 1999-09-10 Battelle Memorial Institute Pulmonary dosing system and method
US6550476B1 (en) 1998-05-21 2003-04-22 Steven L. Ryder Heat-moisture exchanger and nebulization device
US6260549B1 (en) * 1998-06-18 2001-07-17 Clavius Devices, Inc. Breath-activated metered-dose inhaler
US6584976B2 (en) * 1998-07-24 2003-07-01 3M Innovative Properties Company Face mask that has a filtered exhalation valve
GB9821771D0 (en) * 1998-10-06 1998-12-02 Brain Archibald Ian Jeremy Improvements relating to laryngeal mask airway devices
US6463928B1 (en) * 1999-04-06 2002-10-15 Michael Irwin Buisson Pediatric prepatory and induction anesthesia device
US6412488B1 (en) * 1999-05-12 2002-07-02 Respironics, Inc. Low contact nasal mask and system using same
DE29909671U1 (de) * 1999-06-02 1999-09-02 Dräger Medizintechnik GmbH, 23558 Lübeck Kupplung für ein Beatmungsschlauch-System
PT1218049E (pt) * 1999-07-12 2007-01-31 Capnia Inc Aparelho para o alívio de dores de cabeça, rinite e outros padecimentos comuns
AU775872B2 (en) * 1999-08-10 2004-08-19 Fisher & Paykel Healthcare Limited A ventilation system and/or breathing tube
US20070039615A1 (en) * 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
US20060172017A1 (en) * 1999-11-08 2006-08-03 Capnia, Incorporated Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
JP2004500168A (ja) * 1999-11-08 2004-01-08 キャプニア　インコーポレイテッド ガスと薬剤とを共投与して両者の相乗効果で頭痛やアンギナ及び他の症状を軽減するための方法及び装置
IT1310042B1 (it) * 1999-11-26 2002-02-05 Pier Luigi Delvigo Filtro senza spazio morto
DE10007506B4 (de) * 2000-02-18 2006-02-02 Map Medizin-Technologie Gmbh Atemgasschlauchanordnung zur Zufuhr eines Atemgases
AU781522B2 (en) * 2000-03-02 2005-05-26 Fisher & Paykel Healthcare Limited Filter
US6918389B2 (en) * 2000-03-21 2005-07-19 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
US6408848B1 (en) * 2000-03-28 2002-06-25 Ntc Technology, Inc. Method and apparatus for conveniently setting a predetermined volume for re-breathing
IT1318430B1 (it) * 2000-03-29 2003-08-25 Mallinckrodt Holdings B V Dispositivo per l'umidificazione passiva di pazienti tracheostomizzati o intubati.
BR0102116B1 (pt) 2000-05-10 2010-09-21 componente para um membro de circuito de respiração.
US7559324B2 (en) * 2000-06-21 2009-07-14 Fisher & Paykel Healthcare Limited Conduit with heated wick
CA2351183C (en) * 2000-06-21 2008-07-29 Fisher And Paykel Limited Conduit with heated wick
AU2000277264A1 (en) * 2000-09-27 2002-04-08 Steven L. Ryder Heat-moisture exchanger and nebulization device
IT1319876B1 (it) * 2000-11-24 2003-11-03 D E A S S R L Perfezionamenti ai sistemi di broncoaspirazione a circuito chiuso.
DE10134725A1 (de) * 2001-07-17 2003-02-06 Weinmann G Geraete Med Vorrichtung zur Filterung von Atemluft
US7004168B2 (en) * 2001-09-07 2006-02-28 Respironics, Inc. Face mask for gas monitoring during supplemental oxygen delivery
CA2460773C (en) * 2001-09-24 2012-04-10 Atsuo F. Fukunaga Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilisation of fresh gases
US7717109B2 (en) 2001-09-24 2010-05-18 F-Concepts Llc Breathing systems with post-inspiratory valve fresh gas flow input, components for implementing same, and methods of use
US7261105B2 (en) * 2001-09-24 2007-08-28 F-Concepts Llc Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilization of fresh gases
EP1621224A3 (de) 2001-09-24 2006-04-19 FUKUNAGA, Atsuo F. Beatmungskreislauf mit anpassbaren Volumen und Länge
US6698424B2 (en) 2001-12-21 2004-03-02 Kimberly-Clark Worldwide, Inc. Medical connector for a respiratory assembly
GB0205759D0 (en) * 2002-03-12 2002-04-24 Southbank University Entpr Ltd Improved breathing apparatus
US20030196666A1 (en) * 2002-04-22 2003-10-23 Ralph Leonard Safe t-Tube
US7258120B2 (en) * 2002-05-29 2007-08-21 University Of Florida Research Foundation, Inc. Endotracheal tube apparatus and method for using the same to reduce the risk of infections
AU2003244171B2 (en) 2002-09-09 2007-11-15 Fisher & Paykel Healthcare Limited Limb for Breathing Circuit
US7291240B2 (en) 2002-09-09 2007-11-06 Fisher & Paykel Healthcare Limited Method of forming a conduit using a wound sacrificial layer
US7353825B2 (en) 2003-05-01 2008-04-08 Axon Medical, Inc. Apparatus and techniques for reducing the effects of general anesthetics
US7621272B2 (en) * 2003-05-01 2009-11-24 Anecare Laboratories, Inc. Apparatus and techniques for reducing the effects of general anesthetics
US20030188746A1 (en) * 2003-05-13 2003-10-09 Roger Daugherty Apparatus and method for humidification of inspired gases
US20050178381A1 (en) * 2003-05-13 2005-08-18 Roger Daugherty Apparatus and method for humidification of inspired gases
US7007691B2 (en) * 2003-05-13 2006-03-07 Roger Daugherty Apparatus and method for humidification of inspired gases
US7493902B2 (en) 2003-05-30 2009-02-24 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
US7588033B2 (en) 2003-06-18 2009-09-15 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
WO2005018524A2 (en) 2003-08-18 2005-03-03 Wondka Anthony D Method and device for non-invasive ventilation with nasal interface
AU2004203870B2 (en) 2003-09-17 2011-03-03 Fisher & Paykel Healthcare Limited Breathable Respiratory Mask
US7152597B2 (en) * 2003-09-25 2006-12-26 Datex-Ohmeda, Inc. Breathing circuit adapter
CA2540531C (en) * 2003-09-30 2015-02-24 The Research Foundation Of State University Of New York Device and method of partially separating gas
US7178521B2 (en) * 2004-01-09 2007-02-20 King Systems Corporation Adjustable length breathing circuit
EP1729839A2 (de) * 2004-02-12 2006-12-13 FUKUNAGA, Atsuo F. Integrierter mehrfunktionsfilter und atmungsleitung
KR20050097692A (ko) * 2004-04-02 2005-10-10 삼성전자주식회사 광섬유 모재 제작 방법과 광섬유 인출 방법
EP1737525B1 (de) * 2004-04-09 2019-05-22 ResMed Ltd. Nasale maskenanordnung
PT3766534T (pt) 2004-08-20 2022-10-27 Fisher & Paykel Healthcare Ltd Aparelho para medição de propriedades de gases fornecidos a um doente
US20060123001A1 (en) * 2004-10-13 2006-06-08 Copernic Technologies, Inc. Systems and methods for selecting digital advertisements
NZ739443A (en) 2005-01-12 2019-09-27 ResMed Pty Ltd Cushion for patient interface
US7753051B2 (en) 2005-03-18 2010-07-13 King Systems Corporation Face mask strap system
GB0510951D0 (en) 2005-05-27 2005-07-06 Laryngeal Mask Company The Ltd Laryngeal mask airway device
CN101454041B (zh) 2005-09-20 2012-12-12 呼吸科技公司 对患者进行呼吸支持的系统、方法和装置
US8397728B2 (en) 2005-10-14 2013-03-19 Resmed Limited Cushion to frame assembly mechanism
NZ612787A (en) 2005-10-25 2015-01-30 Resmed Ltd Interchangeable mask assembly
US20070169779A1 (en) * 2006-01-24 2007-07-26 Freeman Gary A Reperfusion protection in resuscitation
US10071218B2 (en) 2006-01-24 2018-09-11 Zoll Medical Corporation Reperfusion protection in resuscitation
US7631642B2 (en) 2006-05-18 2009-12-15 Breathe Technologies, Inc. Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
US20100212666A1 (en) * 2006-06-21 2010-08-26 Universitat Bern System for Controlling Administration of Anaesthesia
US8167863B2 (en) * 2006-10-16 2012-05-01 Carefusion 303, Inc. Vented vial adapter with filter for aerosol retention
US8517023B2 (en) 2007-01-30 2013-08-27 Resmed Limited Mask system with interchangeable headgear connectors
NZ589685A (en) 2007-04-19 2012-06-29 Resmed Ltd Cushion for patient breathing interface with variable density foam supported membrane
WO2008144589A1 (en) 2007-05-18 2008-11-27 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
WO2009011907A1 (en) * 2007-07-18 2009-01-22 Vapotherm, Inc. System and method for delivering a heated and humidified gas
AU2008304203B9 (en) 2007-09-26 2014-02-27 Breathe Technologies, Inc. Methods and devices for treating sleep apnea
US8567399B2 (en) 2007-09-26 2013-10-29 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
US8905023B2 (en) 2007-10-05 2014-12-09 Vapotherm, Inc. Hyperthermic humidification system
US20090139528A1 (en) * 2007-12-04 2009-06-04 Olga Yevich Tactile Apparatus and System for Oxygen Tube
WO2009076335A1 (en) * 2007-12-10 2009-06-18 The Cooper Union For The Advancement Of Science And Art Gas delivery system for an animal storage container
US11331447B2 (en) 2008-03-04 2022-05-17 ResMed Pty Ltd Mask system with snap-fit shroud
CN105056361A (zh) 2008-03-04 2015-11-18 瑞思迈有限公司 面罩系统
WO2009129506A1 (en) 2008-04-18 2009-10-22 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
US8967139B2 (en) * 2008-04-29 2015-03-03 Carefusion Corporation Respiratory connector and arrangement for connecting an inspiratory tube and an expiratory tube to a medical apparatus
US9505164B2 (en) 2009-12-30 2016-11-29 Schauenburg Technology Se Tapered helically reinforced hose and its manufacture
DE102008022663B4 (de) 2008-05-07 2012-10-31 Schauenburg Hose Technology Gmbh Stretch-Schlauch
WO2010022363A1 (en) 2008-08-22 2010-02-25 Breathe Technologies, Inc. Methods and devices for providing mechanical ventilation with an open airway interface
US8302602B2 (en) 2008-09-30 2012-11-06 Nellcor Puritan Bennett Llc Breathing assistance system with multiple pressure sensors
WO2010039989A1 (en) 2008-10-01 2010-04-08 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
US20100094417A1 (en) * 2008-10-15 2010-04-15 Christopher Robert Johnson Dual Hook Laryngeal Cable Prosthesis (DHLCP) used to correct airflow in the larynx of horses affected with left recurrent laryngeal neuropathy
KR20100046819A (ko) * 2008-10-28 2010-05-07 포항공과대학교 산학협력단 흡입 마취기
US9964238B2 (en) 2009-01-15 2018-05-08 Globalmed, Inc. Stretch hose and hose production method
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
US20100192947A1 (en) * 2009-02-04 2010-08-05 Jeff Mandel Anesthetic delivery system and methods of use
US7854271B2 (en) * 2009-02-10 2010-12-21 Cnh Canada, Ltd. Marker assembly having rigid link and cam assembly
US8267081B2 (en) 2009-02-20 2012-09-18 Baxter International Inc. Inhaled anesthetic agent therapy and delivery system
GB0903654D0 (en) 2009-03-03 2009-04-15 Laryngeal Mask Company The Ltd Artificial airway device
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
EP3593847B1 (de) 2009-04-02 2023-05-31 Breathe Technologies, Inc. Systeme für nicht-invasive offene beatmung mit gasverabreichungsdüsen in einem äusseren schlauch
WO2010124191A2 (en) 2009-04-24 2010-10-28 New York University System and method for circuits to allow cpap to provide zero pressure
US8485187B2 (en) * 2009-04-28 2013-07-16 Dynasthetics, Llc System, method and apparatus for removal of volatile anesthetics for malignant hyperthermia
NZ597652A (en) 2009-07-06 2014-02-28 Umedaes Ltd Artificial airway
US8499763B2 (en) 2009-07-31 2013-08-06 Covidien Lp Connector for coupling a tracheal tube to an auxiliary device
EP3534128A3 (de) 2009-08-13 2020-01-08 Teleflex Life Sciences Unlimited Company Druckanzeiger
WO2011029074A1 (en) 2009-09-03 2011-03-10 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
GB2473443A (en) * 2009-09-09 2011-03-16 Flexicare Medical Ltd Oxygen therapy apparatus
US11957837B2 (en) * 2009-09-11 2024-04-16 David Smith Method to reduce slosh energy absorption and its damaging effects through the reduction of inelastic collisions in an organism
US8251058B2 (en) 2009-09-29 2012-08-28 Erin Bird Portable sedation apparatus and related method
US8479740B2 (en) * 2009-11-23 2013-07-09 Covidien Lp Airway devices with integral humidification
GB2489178B (en) 2009-12-22 2016-12-14 Fisher & Paykel Healthcare Ltd Components for medical circuits
CN102107038B (zh) * 2009-12-25 2013-04-03 崇仁(厦门)医疗器械有限公司 呼吸面罩的输气管及该呼吸面罩
FR2963740B1 (fr) * 2010-08-12 2012-08-17 Georges Boussignac Systeme d'assistance respiratoire
AU2011292111B2 (en) 2010-08-16 2015-03-26 Breathe Technologies, Inc. Methods, systems and devices using LOX to provide ventilatory support
US8939152B2 (en) 2010-09-30 2015-01-27 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
GB201016562D0 (en) 2010-10-01 2010-11-17 Laryngeal Mask Company The Ltd Artificial airway device
MY173694A (en) 2010-10-15 2020-02-17 Teleflex Life Sciences Unlimited Co Artificial airway device
CN103429291A (zh) 2011-02-02 2013-12-04 梅田有限公司 改进的人工气道
US10500357B2 (en) 2011-03-24 2019-12-10 Koninklijke Philips N.V. Methods and systems to manage central sleep apnea by controlling accumulated retrograde volume
EP4218894A1 (de) 2011-06-03 2023-08-02 Fisher & Paykel Healthcare Limited Medizinische schläuche und herstellungsverfahren dafür
US8291942B2 (en) 2011-11-04 2012-10-23 Blue Gentian, Llc Expandable hose assembly
TWI449870B (zh) * 2011-11-25 2014-08-21 Galemed Corp Temperature and humidity switch
GB201120628D0 (en) 2011-11-30 2012-01-11 Laryngeal Mask Company The Ltd Endoscopy device
US9364624B2 (en) 2011-12-07 2016-06-14 Covidien Lp Methods and systems for adaptive base flow
US9498589B2 (en) 2011-12-31 2016-11-22 Covidien Lp Methods and systems for adaptive base flow and leak compensation
US9022031B2 (en) 2012-01-31 2015-05-05 Covidien Lp Using estimated carinal pressure for feedback control of carinal pressure during ventilation
DE102012002632B4 (de) * 2012-02-10 2024-01-25 Drägerwerk AG & Co. KGaA Beatmungssystem und Konnektorsystem hierfür zur Verminderung von Kontaminationen
CN108042896A (zh) 2012-03-15 2018-05-18 费雪派克医疗保健有限公司 呼吸气体加湿系统
US8844526B2 (en) 2012-03-30 2014-09-30 Covidien Lp Methods and systems for triggering with unknown base flow
US20150096558A1 (en) * 2012-04-23 2015-04-09 David W. Mazyck Helmet air purification system
GB2516199B (en) 2012-04-27 2019-09-04 Fisher & Paykel Healthcare Ltd Respiratory Humidification Apparatus
JP2015534891A (ja) 2012-11-14 2015-12-07 フィッシャー アンド ペイケル ヘルスケア リミテッド 呼吸回路用の区域加熱
US9795756B2 (en) 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
CN108355219B (zh) 2012-12-04 2021-04-02 马林克罗特医疗产品知识产权公司 用于在氧化氮递送期间对给药的稀释最小化的套管
PL2928533T3 (pl) 2012-12-04 2021-05-17 Fisher & Paykel Healthcare Limited Rurki medyczne i sposoby ich wytwarzania
US9492629B2 (en) 2013-02-14 2016-11-15 Covidien Lp Methods and systems for ventilation with unknown exhalation flow and exhalation pressure
US9981096B2 (en) 2013-03-13 2018-05-29 Covidien Lp Methods and systems for triggering with unknown inspiratory flow
DE112014001468T5 (de) 2013-03-15 2015-11-26 Fisher & Paykel Healthcare Limited Komponenten für medizinische Kreisläufe
WO2014142679A1 (en) 2013-03-15 2014-09-18 Fisher & Paykel Healthcare Limited Drying expiratory limb with tailored temperature profile and multi-lumen configuration
DE102013006780B3 (de) * 2013-04-18 2014-09-04 Dräger Medical GmbH Beatmungsschlaucheinheit zum Anschluss an ein medizinisches Beatmungsgerät sowie ein Beatmungssystem umfassend das Beatmungsgerät und mindestens eine Beatmungsschlaucheinheit
GB2587754B8 (en) 2013-09-13 2021-08-04 Fisher & Paykel Healthcare Ltd Humidification Chamber
EP3622993B8 (de) 2013-09-13 2021-08-25 Fisher & Paykel Healthcare Limited Heizsockel mit einem schutz zur steuerung der bewegung einer befeuchterkammer
WO2015060731A1 (en) 2013-10-24 2015-04-30 Fisher & Paykel Healthcare Limited Delivery of respiratory gases
WO2015093989A1 (en) 2013-12-20 2015-06-25 Fisher & Paykel Healthcare Limited Humidification system connections
US10449319B2 (en) 2014-02-07 2019-10-22 Fisher & Paykel Healthcare Limited Respiratory humidification system
JP6731398B2 (ja) 2014-03-17 2020-07-29 フィッシャー アンド ペイケル ヘルスケア リミテッド 呼吸システムのための医療用チューブ
WO2015167347A1 (en) 2014-05-02 2015-11-05 Fisher & Paykel Healthcare Limited Gas humidification arrangement
EP3142737B1 (de) 2014-05-13 2020-07-08 Fisher & Paykel Healthcare Limited Eine anschlusskappe für eine vorrichtung zum anfeuchten von gasen und eine vorrichtung zum anfeuchten von gasen
EP3151894B1 (de) 2014-06-03 2019-08-28 Fisher & Paykel Healthcare Limited Strömungsmischer für atemtherapiesysteme
EP3151895B1 (de) 2014-06-04 2020-04-29 Revolutionary Medical Devices, Inc. Kombination aus nasen- und mundatemmaske
AU2015305893B2 (en) 2014-08-20 2020-05-28 Sunmed Group Holdings, Llc Ventilation mask
EP3220992B1 (de) 2014-11-17 2021-06-23 Fisher & Paykel Healthcare Limited Befeuchtung von atemgasen
USD825740S1 (en) 2014-12-12 2018-08-14 Revolutionary Medical Devices Surgical mask
US10596345B2 (en) 2014-12-31 2020-03-24 Vapotherm, Inc. Systems and methods for humidity control
US9925346B2 (en) 2015-01-20 2018-03-27 Covidien Lp Systems and methods for ventilation with unknown exhalation flow
US9808182B2 (en) 2015-03-20 2017-11-07 Bohnas LLC Breathing detection apparatus
US11247015B2 (en) 2015-03-24 2022-02-15 Ventec Life Systems, Inc. Ventilator with integrated oxygen production
US10315002B2 (en) 2015-03-24 2019-06-11 Ventec Life Systems, Inc. Ventilator with integrated oxygen production
US10398871B2 (en) 2015-03-31 2019-09-03 Vapotherm, Inc. Systems and methods for patient-proximate vapor transfer for respiratory therapy
AU2016275127B2 (en) 2015-06-11 2021-02-25 Sunmed Group Holdings, Llc Ventilation mask
EP4319481A3 (de) 2015-09-09 2024-04-03 Fisher & Paykel Healthcare Limited Zonenheizung für atemkreisläufe
US20170095631A1 (en) * 2015-10-01 2017-04-06 Atsuo F. Fukunaga Resuscitator with distal oxygen inlet, breathing circuits having reusable and disposable components, systems and methods for resuscitation and providing assisted ventilation and anesthesia, and kits and components therefore
US10857321B2 (en) 2015-10-24 2020-12-08 Ambu A/S Breathing circuit systems and devices
WO2017213523A1 (en) 2016-06-07 2017-12-14 Fisher & Paykel Healthcare Limited Breathing circuit components for respiratory apparatus
CN105963838B (zh) * 2016-06-08 2018-12-14 湖南明康中锦医疗科技发展有限公司 一种用于呼吸机的空氧混合结构及呼吸机
US10773049B2 (en) 2016-06-21 2020-09-15 Ventec Life Systems, Inc. Cough-assist systems with humidifier bypass
CN105920711B (zh) * 2016-06-23 2018-09-11 湖南明康中锦医疗科技发展有限公司 一种用于呼吸机的空氧混合气道及呼吸机和方法
EP3487571B8 (de) 2016-07-21 2024-05-01 Fisher & Paykel Healthcare Limited Medizinische schläuche für einen beatmungskreislauf
US9629975B1 (en) 2016-09-14 2017-04-25 Revolutionary Medical Devices, Inc. Ventilation mask
AU2017328060B2 (en) 2016-09-14 2022-09-08 SunMed Group Holdings, LLC. Ventilation mask
CN211383329U (zh) 2016-10-14 2020-09-01 蒸汽热能公司 用于输送呼吸气体的系统
USD848606S1 (en) 2016-11-07 2019-05-14 Revolutionary Medical Devices, Inc. Surgical mask
US11351332B2 (en) 2016-12-07 2022-06-07 Fisher & Paykel Healthcare Limited Sensing arrangements for medical devices
US11311695B2 (en) 2016-12-22 2022-04-26 Fisher & Paykel Healthcare Limited Medical tubes and methods of manufacture
USD817478S1 (en) * 2017-01-25 2018-05-08 Fisher & Paykel Healthcare Limited Exhalation port for breathing circuit
CA3033944C (en) 2017-01-30 2020-02-18 Globalmed, Inc. Heated respiratory hose assembly
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump
USD898188S1 (en) 2017-11-17 2020-10-06 Revolutionary Medical Devices, Inc. Surgical mask
WO2019147142A1 (en) * 2018-01-24 2019-08-01 Fisher & Paykel Healthcare Limited Medical tubes for breathing circuit
JP2021524795A (ja) 2018-05-13 2021-09-16 サミール・サレハ・アフマド ポータブル酸素濃縮器を使用するポータブル医療用人工呼吸器システム
EP3965859A4 (de) * 2019-05-08 2022-06-29 Respinova Ltd. System zur verabreichung von inhalationstherapien
CN115243624A (zh) * 2020-03-06 2022-10-25 波士顿科学国际有限公司 用于输送粉末状药剂的装置
US12064562B2 (en) 2020-03-12 2024-08-20 Vapotherm, Inc. Respiratory therapy unit with non-contact sensing and control
USD1047135S1 (en) 2021-06-18 2024-10-15 Fisher & Paykel Healthcare Limited Exhalation port for breathing circuit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265235A (en) * 1979-05-11 1981-05-05 Fukunaga Atsuo F Anesthetic system

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT93941B (de) * 1913-11-12 1923-08-10 Draegerwerk Heinr U Bernh Unabhängiger Atmungsapparat.
US2971532A (en) * 1956-04-05 1961-02-14 Smith Corp A O Water heater fitting for delivering two temperatures of heated water
GB1270946A (en) * 1968-07-22 1972-04-19 British Oxygen Co Ltd Breathing tube assembly
US3556097A (en) * 1969-09-25 1971-01-19 Air Reduction Disposable anesthesia-breathing circuit unit
US3713440A (en) * 1971-01-18 1973-01-30 P Nicholes Filtration system
US3856051A (en) * 1972-02-28 1974-12-24 J Bain Flexible tube device
US3858615A (en) * 1972-12-11 1975-01-07 Puritan Bennett Corp Flexible hose construction
US3894540A (en) * 1973-10-09 1975-07-15 Bonner F J Jun Catheter
IT1001622B (it) * 1973-11-05 1976-04-30 Malleni R Sistema e dispositivo perfezionato per respirazione artificiale in particolare nel campo pediatrico
US4007737A (en) * 1974-01-28 1977-02-15 Paluch Bernard R Anesthesia breathing system
US3865106A (en) * 1974-03-18 1975-02-11 Bernard P Palush Positive pressure breathing circuit
US4148732A (en) * 1977-04-05 1979-04-10 Burrow Clovis E Bacteria filter unit
US4188946A (en) * 1977-10-07 1980-02-19 Rayburn Robert L Controllable partial rebreathing anesthesia circuit and respiratory assist device
US4269194A (en) * 1978-02-13 1981-05-26 Rayburn Robert L Carbon dioxide measurement from expired gases in a partial rebreathing anesthesia circuit
US4367769A (en) * 1978-07-17 1983-01-11 James Bain Safety connector for flexible tube device
US4232667A (en) * 1978-09-05 1980-11-11 Jack Chalon Single limb breathing circuit assembly and absorber
ZA785078B (en) * 1978-09-07 1980-08-27 D Miller Anaesthesia apparatus
DE2929584A1 (de) * 1979-07-21 1981-02-05 Draegerwerk Ag Feuchtigkeitsaustauscher in einrichtungen fuer die atmung
US4657532A (en) * 1985-07-19 1987-04-14 Thomas Jefferson University Intra-peritoneal perfusion of oxygenated fluorocarbon
SE430304B (sv) * 1980-09-01 1983-11-07 Testa Lab A S Anestesirespirationsapparat
US4676239A (en) * 1980-09-20 1987-06-30 David Humphrey Anesthetic system
US4462397A (en) * 1981-04-03 1984-07-31 Terumo Corporation Breathing circuit
US4391271A (en) * 1981-04-06 1983-07-05 Albert Blanco Respirator circuit
US4463755A (en) * 1981-05-18 1984-08-07 Terumo Corporation Breathing circuit
US4573236A (en) * 1983-07-08 1986-03-04 Prototypes, Ltd. Vacuum cleaning appliances
US4621634A (en) * 1984-01-27 1986-11-11 Trutek Research, Inc. Anesthesia tubing connections
US4596246A (en) * 1984-02-24 1986-06-24 Lyall Robert N Method and apparatus for converting patient breathing system between circle and non-rebreathing configurations
US4568334A (en) * 1984-04-25 1986-02-04 Lynn Lawrence A Intravascular catheter preparation and dispensing container assembly
WO1985005277A1 (en) * 1984-05-18 1985-12-05 Clawson Burrell E Respiratory system corrugated flow lines and fittings
GB8432814D0 (en) * 1984-12-31 1985-02-06 Lifeline Ltd Catheter mount assembly
US4637384A (en) * 1985-02-15 1987-01-20 The Boc Group, Inc. Coaxial breathing circuit
US5002050A (en) * 1986-09-17 1991-03-26 Mcginnis Gerald E Medical gas flow control valve, system and method
US5377670A (en) * 1986-09-23 1995-01-03 Smith; Charles A. Insulated breathing tube
US5623922A (en) * 1986-09-23 1997-04-29 Smith; Charles A. Insulated breathing tube
US4838258A (en) * 1987-10-26 1989-06-13 Gibeck-Dryden Corporation Gas sampling lumen for breathing system
US4809706A (en) * 1988-01-13 1989-03-07 Watson Robert L Incentive inhalation spirometer apparatus
US4967744A (en) * 1988-11-03 1990-11-06 Airoflex Medical, Inc. Flexible breathing circuit
US4938210A (en) * 1989-04-25 1990-07-03 Trudell Medical Inhalation chamber in ventilator circuit
GB8911627D0 (en) * 1989-05-19 1989-07-05 Intersurgical Guernsey Ltd Improvements in filters
US5184850A (en) * 1989-07-07 1993-02-09 Georg Fischer Ag Method of connecting pipes of plastics material of a double pipe system and a pipe connection made by the method
CH679240A5 (de) * 1989-07-07 1992-01-15 Fischer Ag Georg
CA2004930C (en) * 1989-12-08 1996-04-02 John Richard Sikora Anaesthetic and respirator breathing circuit device
US5088486A (en) * 1990-04-11 1992-02-18 Jinotti Walter J Closed system reusable dual purpose catheter
US5140983A (en) * 1990-04-11 1992-08-25 Jinotti Walter J Multi purpose catheter assembly
NZ238544A (en) * 1990-06-18 1994-10-26 Ponnet Gilman En Anthony Respirator with hygroscopic material adjacent outlet to patient
DK0462412T3 (da) * 1990-06-18 1996-08-12 Engstrom Medical Ab Y-formet tilslutningsstykke til åndedrætsapparat
US5203384A (en) * 1990-08-15 1993-04-20 Dresser Industries, Inc. Combination casting for a blending dispenser
US5320093A (en) * 1990-12-21 1994-06-14 Brigham And Women's Hospital Rapid anesthesia emergence system using closed-loop PCO2 control
CN2093651U (zh) * 1991-06-07 1992-01-22 天津市第二中心医院 兼容型麻醉用呼吸回路装置
US5402831A (en) * 1991-08-01 1995-04-04 Asahi/America, Inc. Restraint coupling assembly for double containment pipe system
US5284160A (en) * 1991-11-13 1994-02-08 Dryden Gale E Consolidated anesthesia circuit
DE4204530A1 (de) * 1992-02-15 1993-08-19 Asea Brown Boveri Rohrsystem
US5230727A (en) * 1992-06-05 1993-07-27 Cybermedic, Inc. Air filter for medical ventilation equipment and the like
EP0590289A1 (de) * 1992-09-28 1994-04-06 Engström Medical Ab Patientenanschluss
US5398675A (en) * 1992-10-14 1995-03-21 Henkin; Melvyn L. Anesthesia rebreathing system
US5404873A (en) * 1993-06-16 1995-04-11 King System Corporation Division Of Barco Molding, Inc. Anesthesia circuit
US5419593A (en) * 1993-10-22 1995-05-30 Conley Corporation Interlocking union for double containment pipe
US5823184A (en) * 1994-04-18 1998-10-20 Tyco International (Us) Inc. Breathing circuit
US5598840A (en) * 1995-03-17 1997-02-04 Sorenson Critical Care, Inc. Apparatus and method for ventilation and aspiration
WO1996030069A1 (en) * 1995-03-28 1996-10-03 Ballard Medical Products Anti-contaminating catheter sheath with filter/closure barriers
US5901705A (en) * 1996-10-17 1999-05-11 King Systems Corporation Sleeved filter for a breathing circuit
US5722391A (en) * 1996-11-12 1998-03-03 Par Medical, Inc. Anesthesia tube assembly
US6003511A (en) * 1996-11-18 1999-12-21 Medlis Corp. Respiratory circuit terminal for a unilimb respiratory device
US5778872A (en) * 1996-11-18 1998-07-14 Medlis, Inc. Artificial ventilation system and methods of controlling carbon dioxide rebreathing
US6306098B1 (en) 1996-12-19 2001-10-23 Novametrix Medical Systems Inc. Apparatus and method for non-invasively measuring cardiac output
US6079410A (en) * 1998-07-06 2000-06-27 Q.D.S. Injection Molding, Inc. Collapsible snorkel
US6152131A (en) 1998-08-26 2000-11-28 Instrumentarium Corp. Method and apparatus for detecting an empty breathing gas compartment in a patient ventilator
US6217569B1 (en) * 1999-05-10 2001-04-17 John M. Fiore Integral shroud-collector for urinary catheter
US6537254B1 (en) * 1999-07-06 2003-03-25 Datascope Investment Corp. Universal protective catheter sleeve
JP2003505214A (ja) 1999-08-03 2003-02-12 ブラッドリー ピー．ファーマン 振動換気装置内のバイアスフローを低減する装置および方法
EP1621224A3 (de) 2001-09-24 2006-04-19 FUKUNAGA, Atsuo F. Beatmungskreislauf mit anpassbaren Volumen und Länge

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265235A (en) * 1979-05-11 1981-05-05 Fukunaga Atsuo F Anesthetic system

Also Published As

Publication number Publication date
EP1155709A2 (de) 2001-11-21
CN1237915A (zh) 1999-12-08
CN1177626C (zh) 2004-12-01
US20050022828A1 (en) 2005-02-03
JP2004089698A (ja) 2004-03-25
DE69730540D1 (de) 2004-10-07
CA2270541A1 (en) 1998-05-28
EP1157714A2 (de) 2001-11-28
US7418965B2 (en) 2008-09-02
DE69730540T2 (de) 2005-09-01
EP1484076A2 (de) 2004-12-08
JP2000503885A (ja) 2000-04-04
JP3466203B2 (ja) 2003-11-10
EP1157714A3 (de) 2002-07-24
CN1593680A (zh) 2005-03-16
US5778872A (en) 1998-07-14
US5983891A (en) 1999-11-16
EP1155709A3 (de) 2002-01-23
TW357089B (en) 1999-05-01
CN1613520A (zh) 2005-05-11
US5983896A (en) 1999-11-16
ATE242023T1 (de) 2003-06-15
DE69722684T2 (de) 2004-04-29
ATE246017T1 (de) 2003-08-15
EP0942763B1 (de) 2003-07-30
CN100352521C (zh) 2007-12-05
CA2270541C (en) 2007-01-09
PT942763E (pt) 2003-11-28
EP0942763A4 (de) 2000-11-15
IL129586A0 (en) 2000-02-29
EP1155709B1 (de) 2003-06-04
WO1998022172A1 (en) 1998-05-28
EP1484076A3 (de) 2007-03-28
EP0942763A1 (de) 1999-09-22
JP2004073853A (ja) 2004-03-11
ZA9710216B (en) 1998-06-03
AU5242798A (en) 1998-06-10
CA2708934C (en) 2011-08-16
DE69723859T2 (de) 2004-05-13
CA2708934A1 (en) 1998-05-28
IL129586A (en) 2009-09-22
HK1023954A1 (en) 2000-09-29
DE69723859D1 (de) 2003-09-04
HK1072387A1 (en) 2005-08-26
JP2006150094A (ja) 2006-06-15
US5983894A (en) 1999-11-16
BR9713000A (pt) 2000-01-25
ATE274958T1 (de) 2004-09-15
NZ335100A (en) 2001-02-23
ES2205260T3 (es) 2004-05-01
AU732019B2 (en) 2001-04-12
DE69722684D1 (de) 2003-07-10
JP2001231862A (ja) 2001-08-28
CN1613520B (zh) 2013-07-10
EP2272558A2 (de) 2011-01-12
JP4464925B2 (ja) 2010-05-19
JP3709400B2 (ja) 2005-10-26
JP3696792B2 (ja) 2005-09-21

Similar Documents

Publication Publication Date Title
EP1157714B1 (de) Beatmungssystem mit eingliedrigem Beatmungsrohr
US6003511A (en) Respiratory circuit terminal for a unilimb respiratory device
US6439231B1 (en) Artificial ventilation systems and components thereof, and methods for providing, assembling and utilizing same
JP4348182B2 (ja) 通常とは異なる呼吸導管を有する呼吸回路、及び新鮮ガスを最適に利用するシステム及び装置
CA2538926C (en) Artificial ventilation system and methods of controlling carbon dioxide rebreathing
AU747499B2 (en) Respiratory conduit
AU743183B2 (en) Multilumen filter device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010817

AC Divisional application: reference to earlier application

Ref document number: 942763

Country of ref document: EP

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030219

AKX Designation fees paid

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: BREATHING SYSTEM WITH UNILIMB RESPIRATORY CONDUIT

RTI1 Title (correction)

Free format text: BREATHING SYSTEM WITH UNILIMB RESPIRATORY CONDUIT

RTI1 Title (correction)

Free format text: BREATHING SYSTEM WITH UNILIMB RESPIRATORY CONDUIT

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 0942763

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20040901

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040901

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040901

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040901

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040901

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040901

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040901

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040901

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69730540

Country of ref document: DE

Date of ref document: 20041007

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20041201

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20041201

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20041201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20041212

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

26N No opposition filed

Effective date: 20050602

EN Fr: translation not filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050201

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20151028

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20161025

Year of fee payment: 20

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20161030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161030

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69730540

Country of ref document: DE